Detailed Information on Publication Record
2020
Variability in the Clearance of Lead Oxide Nanoparticles Is Associated with Alteration of Specific Membrane Transporters
DUMKOVÁ, Jana, Tereza SMUTNÁ, Lucie VRLÍKOVÁ, Hana KOTASOVÁ, Bohumil DOČEKAL et. al.Basic information
Original name
Variability in the Clearance of Lead Oxide Nanoparticles Is Associated with Alteration of Specific Membrane Transporters
Authors
DUMKOVÁ, Jana (203 Czech Republic, belonging to the institution), Tereza SMUTNÁ (203 Czech Republic, belonging to the institution), Lucie VRLÍKOVÁ, Hana KOTASOVÁ (203 Czech Republic, belonging to the institution), Bohumil DOČEKAL, Lukáš ČAPKA, Michaela KUCHYNKA (203 Czech Republic, belonging to the institution), Veronika JAKEŠOVÁ, Vendula PELKOVÁ (203 Czech Republic, belonging to the institution), Kamil KŘŮMAL, Pavel COUFALÍK, Pavel MIKUŠKA, Zbyněk VEČEŘA, Tomáš VACULOVIČ (203 Czech Republic, belonging to the institution), Zuzana HUSÁKOVÁ (203 Czech Republic, belonging to the institution), Viktor KANICKÝ (203 Czech Republic, belonging to the institution), Aleš HAMPL (203 Czech Republic, belonging to the institution) and Marcela BUCHTOVÁ (203 Czech Republic, guarantor, belonging to the institution)
Edition
ACS Nano, Washington, D.C. American Chemical Society, 2020, 1936-0851
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30108 Toxicology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 15.881
RIV identification code
RIV/00216224:14310/20:00114474
Organization unit
Faculty of Science
UT WoS
000526301400044
Keywords in English
clearance; nanoparticles; lead oxide; inhalation; ABC transporters; caveolins; LA-ICP-MS imaging
Tags
International impact, Reviewed
Změněno: 17/2/2023 12:07, Mgr. Marie Šípková, DiS.
Abstract
V originále
Lead oxide nanoparticles (PbONPs), upon their entry into the lungs via inhalation, induce structural changes in primary and secondary target organs. The fate and ultrastructural localization of PbONPs in organs is known to be dependent on the specific organ. Here, we focused on the differences in the ability to clear the inhaled PbONPs from secondary target organs and on molecular and cellular mechanisms contributing to nanoparticle removal. Mice were exposed to PbONPs in whole-body inhalation chambers. Clearance of ionic lead and PbONPs (Pb/PbONPs) from the lungs and liver was very effective, with the lead being almost completely eliminated from the lungs and the physiological state of the lung tissue conspicuously restored. Kidneys exposed to nanoparticles did not exhibit serious signs of damage; however, LA-ICP-MS uncovered a certain amount of lead located preferentially in the kidney cortex even after a clearance period. The concentration of lead in femurs, as representatives of the axial skeleton, was the highest among studied organs at all designated time points after PbONP exposure, and the clearance ability of lead from the femurs was very low in contrast to other organs. The organ-specific increase of ABC transporters expression (ABCG2 in lungs and ABCC3 in the liver) was observed in exposed animals, suggesting their involvement in removing Pb/PbONPs from tissues. Moreover, the expression of caveolins and clathrin displayed a tissue-specific response to lead exposure. Our results uncovered high variability among the organs in their ability to clear Pb/PbONPs and in the transporters involved in this process.
Links
GA17-12774S, research and development project |
| ||
GA20-02203S, research and development project |
|